APA (7th ed.) Citation
(2025). Correction to “Usefulness of Sarilumab in Patients with Rheumatoid Arthritis after Regression of Lymphoproliferative Disorders”. Case Reports in Rheumatology.
Chicago Style (17th ed.) Citation
"Correction to “Usefulness of Sarilumab in Patients with Rheumatoid Arthritis After Regression of Lymphoproliferative Disorders”." Case Reports in Rheumatology 2025.
MLA (9th ed.) Citation
"Correction to “Usefulness of Sarilumab in Patients with Rheumatoid Arthritis After Regression of Lymphoproliferative Disorders”." Case Reports in Rheumatology, 2025.
Warning: These citations may not always be 100% accurate.